Our visionmulti pep diabetes trial_BRC

Through the Institute of Diabetes, Obesity and Endocrinology we will work collaboratively with our partners in Primary Care, Public Health, Local Government, Third Sector, and Industry, to improve the mental and physical health of our patients and wider population.

We will do this by delivering a world-class clinical, research, and education offer that directly improves quality and access to diabetes, obesity and endocrinology care, achieves parity across mental and physical health, and leads the development of highly innovative solutions that support prevention, better self-management of care, and reduced episodes of health deterioration.

Our Institute programme is led by highly regarded clinicians and academics who are world leaders in the fields of diabetes medicine and research.

Read our latest diabetes, obesity and endocrinology news.

Our clinical strengths

Collectively, King’s Health Partners is the largest provider of diabetes and endocrinology services in the UK. We serve a large, culturally diverse population of around two million patients across a wide reaching geographical area spanning greater London and the South East.

We run the UK’s largest type 1 diabetes and pump service, with in excess of 1,000 pump users, and we provide network leadership on the management of type 1 diabetes across south east London and south east England. We lead the national service for problematic hypoglycaemia, using cutting-edge technology and transplantation treatments. 

In type 2 diabetes we are global leaders in the implementation of innovative and novel approaches to type 2 diabetes management. We are the UK’s leading referral centre for advanced diabetes complications, in particular diabetic foot, autonomic neuropathy, and nephropathy. In obesity we are the South East England regional hub for bariatric surgery and are aiming to carrying out in excess of 700 procedures per year. We are scoping and testing new ways of delivering care, the use of non-surgical treatments, and the use of technology to provide obesity treatment and prevention interventions at scale.

Through the Institute we will build on this to deliver:

  • Scalable and transferable innovation and excellence through transforming the way we deliver care and establishing ‘first ever’ clinics to treat patients in new ways using new techniques, devices, and therapies
  • A comprehensive clinical offer delivered through a holistic pathway of care, by treating the whole person through integrating mental and physical health
  • A hub and spoke Diabetes Foot Programme delivered through a one-team collaborative venture across our Sustainability and Transformation Partnership area and parts of Kent
  • Test new and highly innovative clinical procedures and models of care for, and on behalf of, the wider system, e.g. fractyl endoscopic duodenal resurfacing, and working with Medtronic to explore opportunities to test the Diabeter model of care to deliver enhanced type 1 care
  • A comprehensive, unified, Tier 3 and 4 obesity programme for south east London. Focusing on the life genesis of obesity and related metabolic disease, especially prevention and behavioural aspects, and surgical and minimally invasive procedures
  • Lead joint clinical testing with King’s College London Transcampus Initiative in areas such as Alcoholic Fatty Liver Disease and lipopheresis
  • Development of a comprehensive tertiary endocrinology service
  • Growth of telemedicine and “virtual” clinics. 

Our research strengthsDiabetes research

King’s Health Partners has a number of distinctive academic international strengths across the spectrum of diabetes and obesity research. 26% of our research papers submitted to the Research Excellence Framework (REF) were rated ‘world leading’, and 74% were ‘internationally excellent’. Since 2014, the Diabetes, Endocrinology and Obesity Clinical Academic Group has published more than 600 research articles and amassed more than 6,000 citations.

All of our research endeavours have major potential for both scale and global health impact. An example of this is the research published by the Peakman Group on the search for a diabetes vaccine.  

Through the Institute we aim to build on these successes with an aspiration to be a major UK centre in the field of diabetes and obesity research. We will:

  • Develop a word-class, world first, research strategy spanning beta cell health and disease including immunology, transplantation and beta cell biology
  • Focus on type 1 diabetes research in terms of cures and transplantations
  • Drive growth and collaborative development of a world-class obesity research programme with links to metabolic liver disease and behavioural change
  • Develop new collaborations, especially within the Transcampus Initiative to explore greater understanding between diabetes, pre-diabetes, and other systemic disease
  • Ensure research programmes are positioned to collaborate with cross-cutting themes across the School of Life Course Science at King’s College London
  • Explore opportunities for co-location of islet and gut physiology, cell replacement, islet transplant and metabolic surgery, along with creation of joint wet labs and a clinical trials office.

A cure for diabetes through surgery?

Watch this video from The Economist featuring Professor Rubino Francesco, Chair of Bariatric Surgery at King's College London, discussing his innovative work on finding a cure for type 2 diabetes through surgery.


Our education strengthselearning

King’s College London, as part of King’s Health Partners, has a long history of setting the national and international standards for diabetes, nutrition, and metabolic clinical education. 

Through our Institute we will build on this success and create a highly innovative online offer that creates a globally accessible hub for learning that is available 24/7. Fostering a virtual ‘education city’ that students can tailor to their personal learning needs. We will develop a world-class education offer including a Transcampus PhD programme and the provision of an unrivalled range of multidisciplinary postgraduate education modular programmes and short courses in diabetes, endocrinology, and metabolic medicine.  Our intention is to create an internationally recognised modular multidisciplinary MSc programme spanning mental and physical health. 

Access free diabetes, obesity and endocrinology elearning for King’s Health Partners staff.

Mind & Body

When diabetes is combined with mental illness it leads to worse outcomes than either condition alone. The association between diabetes and mental illness is well recognised, but despite this, integrated care for these patients remains poor, and commissioned services to improve care for these patients are almost non-existent. Currently, mental health services lack diabetes skills and diabetes services do not have mental health skills. Primary care alone does not have the resources to manage multi-morbidity. This leads to inequity of access to care and patients fall between the ‘net’ in services. 

We are one of the few teams of staff to have world leading clinical and academic leadership in the mind-body approach to diabetes care that encompasses psychiatry, immunology, beta-cell biology, education, therapies, and the use of data and informatics to improve patient care. 

We have developed and led a number of transformational improvement and clinical leadership programmes in this field including:

The Institute will lead by example delivering innovation and improvements in clinical, academic, education, and prevention activity and by integrating mind and body to support local, regional, and national policy.

> Back to Institutes